ODDB.org: Open Drug Database

Pfizer AG - Comirnaty, Konzentrat zur Herstellung einer Injektionsdispersion

Swissmedic Registration	68225	Sequence	01
Product name	Comirnaty	Description	Konzentrat zur Herstellung einer Injektionsdispersion
ATC-Classification	J07BN01	ATC-Description
Introduction of Sequence	19.12.2020

Composition

tozinameranum 30 µg pro dosi, ((4-hydroxybutyl)azanediyl)bis(hexane-6,1-diylis)bis(2-hexyldecanoas) pro dosi, 2-(polyethylenglycoli 2000)-N,N-ditetradecylacetamidum pro dosi, 1,2-distearoyl-sn-glycero-3-phosphocholinum pro dosi, cholesterolum pro dosi, saccharum pro dosi, natrii chloridum pro dosi, natrii hydroxidum, dinatrii phosphas dihydricus pro dosi, kalii dihydrogenophosphas pro dosi, kalii chloridum pro dosi, acidum hydrochloridum, aqua ad iniectabile, natrium 0.16 mg et kalium 0.01 mg pro dosi.

Packungsbestandteile

Galenic Form

Konzentrat zur Herstellung einer Injektionsdispersion

Excipiens

Active Agent	Dose
Tozinameranum	225 µg

Inactive agents
1,2-distearoyl-Sn-Glycero-3-Phosphocholinum
2-(Polyethylenglycoli 2000)-n,n-Ditetradecylacetamidum
Cholesterol
Disodium Phosphate Dihydrate
Potassium Chloride
Potassium Dihydrogenophosphate
Sodium Chloride
Saccharum

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
No entries have been found.

2025	©ywesee GmbH